Patients with depression are less likely to receive guideline-concordant outpatient depression treatment if they have co-occurring substance use disorder, researchers found in a study published online in The American Journal of Psychiatry.
Doses of psilocybin, provided in combination with supporting psychotherapy, was found to produce significant reductions in symptoms of major depression in a study conducted by researchers at Johns Hopkins University.
While social media was rewarding to many users looking for informational, emotional, and peer support when the COVID-19 pandemic hit, excessive use led to mental health issues, according to a study published in Computers in Human Behavior.
Zuranolone, an investigational neuroactive steroid, improved depressive symptoms in a majority of patients within a 14-day treatment course, topline results from an ongoing phase 3 open-label study show.
The use of psychedelics in psychotherapy can help patients go beyond ameliorating symptoms and confront their root causes of depression, Andrew D. Penn, RN, MS, NP, CNS, APRN-BC, and Charles Raison, MD, said at a session at the Psych Congress 2020…
Daily social media use is neither a strong nor consistent risk factor for depressive symptoms in adolescents in the United States, according to a new study published in the Journal of Adolescent Health.
Michael E. Thase, MD, spoke at the 2020 Psych Congress Elevate conference on adjunctive and combination therapies for difficult-to-treat depression. Here, he answers some of the questions asked by attendees.